Cytokinetics, Incorporated · NASDAQ:CYTK
The Vanguard Group reported a 10.09% stake in Cytokinetics, Incorporated (Schedule 13G/A)
Event Dec 31, 2024 · Filed Jan 8, 2025
The Vanguard Group reported a 10.09% stake in Cytokinetics, Incorporated, 11,915,821 shares, as a passive investor on Dec 31, 2024. Filed Jan 8, 2025 (Schedule 13G/A).
- Stake
- 10.09%
- Shares
- 11,915,821
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 10.09% | 11,915,821 |
Source
Related
- Cytokinetics, Incorporated
- The Vanguard Group
- Cytokinetics, Incorporated shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Form 4 · Malik Fady Ibraham · Oct 20, 2026
- Form 4 · Daly James M · Oct 20, 2026
- Form 4 · Henderson John T · Oct 20, 2026
- Form 4 · Wysenski Nancy · Oct 20, 2026
- Form 4 · Harrington Robert Arthur · Oct 20, 2026